Serum TSH within the reference range as a predictor of future hypothyroidism and hyperthyroidism: 11-Year follow-up of the HUNT study in Norway

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages 93-99

  Åsvold, Bjørn Olav ^a,b   Vatten, Lars J ^a   Midthjell, Kristian ^c   Bjøro, Trine ^d  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; THIONAMIDE; THYROTROPIN;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR CLINICAL STUDY; MALE; NORWAY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; THYROTROPIN BLOOD LEVEL;

ASYMPTOMATIC DISEASES; COHORT STUDIES; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MALE; MIDDLE AGED; NORWAY; PROGNOSIS; REFERENCE VALUES; RISK FACTORS; THYROTROPIN; TIME FACTORS;

EID: 84855508494     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1724     Document Type: Article

References (21)

1. Effraimidis G, Strieder TG, Tijssen JG, Wiersinga WM 2011 Natural history of the transition from euthyroidism to overt autoimmune hypo- or hyperthyroidism: a prospective study. Eur J Endocrinol 164:107-113
2. Andersen S, Pedersen KM, Bruun NH, Laurberg P 2002 Narrow individual variations in serum T(4) and T(3) in normal subjects: a clue to the understanding of subclinical thyroid disease. J Clin Endocrinol Metab 87:1068-1072 (Pubitemid 36121067)
3. Surks MI, Goswami G, Daniels GH 2005 The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab 90:5489-5496 (Pubitemid 41262321)
4. Geul KW, van Sluisveld IL, Grobbee DE, Docter R, de Bruyn AM, Hooykaas H, van der Merwe JP, van Hemert AM, Krenning EP, Hennemann G, Weber RFA 1993 The importance of thyroid microsomal antibodies in the development of elevated serum TSH in middle-aged women: associations with serum lipids. Clin Endocrinol (Oxf) 39:275-280 (Pubitemid 23274425)
5. Strieder TG, Tijssen JG, Wenzel BE, Endert E, Wiersinga WM 2008 Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score. Arch Intern Med 168:1657-1663
6. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C 2006 Effect of iodine intake on thyroid diseases in China. N Engl J Med 354:2783-2793 (Pubitemid 43974196)
7. Vanderpump MP, Tunbridge WM, French JM, Appleton D, Bates D, Clark F, Grimley Evans J, Hasan DM, Rodgers H, Tunbridge F, Young ET 1995 The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55-68
8. Walsh JP, Bremner AP, Feddema P, Leedman PJ, Brown SJ, O'Leary P 2010 Thyrotropin and thyroid antibodies as predictors of hypothyroidism: a 13-year, longitudinal study of a community-based cohort using current immunoassay techniques. J Clin Endocrinol Metab 95:1095-1104
9. Warren RE, Perros P, Nyirenda MJ, Frier BM 2004 Serum thyrotropin is a better predictor of future thyroid dysfunction than thyroid autoantibody status in biochemically euthyroid patients with diabetes: implications for screening. Thyroid 14:853-857 (Pubitemid 39489011)
10. Ramasamy V, Kadiyala R, Fayyaz F, Mallipedhi A, Baglioni P, Okosieme OE 2011 Value of baseline serum thyrotropin as a predictor of hypothyroidism in patients with diabetes mellitus. Endocr Pract 17:26-32
11. Bjøro T, Holmen J, Krüger Ø, Midthjell K, Hunstad K, Schreiner T, Sandnes L, Brochmann H 2000 Prevalence of thyroid disease, thyroid dysfunction and thyroid peroxidase antibodies in a large, unselected population. The Health Study of Nord-Trøndelag (HUNT). Eur J Endocrinol 143:639-647
12. Holmen J, Midthjell K, Krüger Ø, Langhammer A, Holmen TL, Bratberg GH, Vatten LJ, Lund-Larsen PG 2003 The Nord-Trøndelag Health Study 1995-97 (HUNT 2): objectives, contents, methods, and participation. Norsk Epidemiol 13:19-32
13. Reinehr T 2010 Obesity and thyroid function. Mol Cell Endocrinol 316:165-171
14. Holm IA, Manson JE, Michels KB, Alexander EK, Willett WC, Utiger RD 2005 Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Arch Intern Med 165:1606-1611 (Pubitemid 41124154)
15. Effraimidis G, Tijssen JG, Wiersinga WM 2009 Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab 94:1324-1328
16. Kapelrud H, Frey H, Theodorsen L 1987 [Excretion of iodine in the urine.Astudy from 6 different Norwegian districts in 1985]. Tidsskr Nor Laegeforen 107:1320-1321, 1317
17. Spencer CA, Hollowell JG, Kazarosyan M, Braverman LE 2007 National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSHupper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab 92:4236-4240 (Pubitemid 350074737)
18. Rosario PW 2010 Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study. Clin Endocrinol (Oxf) 72:685-688
19. Vadiveloo T, Donnan PT, Cochrane L, Leese GP 2011 The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab 96:E1-E8
20. Biondi B, Cooper DS 2008 The clinical significance of subclinical thyroid dysfunction. Endocr Rev 29:76-131 (Pubitemid 351252748)
21. Wartofsky L, Dickey RA 2005 The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 90: 5483-5488 (Pubitemid 41262320)